Myomo 

€0.000000
79
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11AugExpected
Q1 2026
Next
-0.1
-0.08
-0.07
-0.06
Expected EPS
-0.0858039
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0M6.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ekso Bionics
EKSO
Mkt Cap42.05M
Ekso Bionics designs and manufactures powered exoskeletons which can be used for rehabilitation and mobility, directly competing with Myomo's mobility enhancement devices.
Resmed
RMD
Mkt Cap30.41B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Smith & Nephew
SNN
Mkt Cap12.78B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap106.49B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap10.88B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Show more...
CEO
Mr. Paul R. Gudonis
Employees
184
Country
United States
ISIN
US62857J1025

Listings

0 Comments

Share your thoughts

FAQ

What is Myomo stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Myomo stocks are traded under the ticker 0M6.STU.
When is the next Myomo earnings date?
Myomo is going to release the next earnings report on August 11, 2026.
What were Myomo earnings last quarter?
0M6.STU earnings for the last quarter are -0.06 EUR per share, whereas the estimation was -0.1 EUR resulting in a +38.6% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Myomo have?
As of July 10, 2026, the company has 184 employees.
In which sector is Myomo located?
Myomo operates in the Health & Wellness sector.
When did Myomo complete a stock split?
Myomo has not had any recent stock splits.
Where is Myomo headquartered?
Myomo is headquartered in Burlington, United States.